The effect of novel iron-containing phosphate binder,ferric citrate, to serum P,Ca,and iron metabolic markers on HD patients.

The effect of novel iron-containing phosphate binder,ferric citrate, to serum P,Ca,and iron metabolic markers on HD patients. - The effect of novel iron-containing phosphate binder,ferric citrate, to serum P,Ca,and iron metabolic markers on HD patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220207

Enrollment

Registered

2015-01-14

Start date

2014-09-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HD Patients

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HD Patients

Exclusion criteria

Exclusion criteria: 100<Serum Ferritin

Design outcomes

Primary

Measure	Time frame
Serum concentration of Ca,P,Iron regulatory factors.	—

Countries

Japan

Contacts

Public ContactShigeru Miyazaki

Shinraku-en Hospital

byori@shinrakuen.com+81-25-260-8200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026